NCT03933631RecruitingPhase 3

Pilocarpine Use After Kahook Goniotomy

A Prospective Randomized Control Trial of Pilocarpine Use After Combined Cataract/Kahook Dual Blade Surgery

Source: ClinicalTrials.gov · Last updated 10 Nov 2025

Brief summary (registry, in English)

The goal of this study is to determine whether using pilocarpine provides added benefit to the success of combined cataract + Kahook Dual Blade (KDB) surgery.

Status (registry): Recruiting
Phase (registry): Phase 3
Study type: Interventional
Enrollment: 142 (estimated)
First submitted: 26 Apr 2019
Start date: 1 May 2019
Primary completion date: Jun 2028
Lead sponsor: Montefiore Medical Center
Diseases: Glaucoma
NCT number: NCT03933631

What you commit to

Study type: Interventional · Phase 3
Planned participants: 142
From 1 May 2019 to the primary completion date, Jun 2028
2 sites in 1 country
Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

Patients with previous history of eye surgeries (including laser procedures)

Who the study is looking for

Patients with ocular hypertension or open angle glaucoma undergoing combined cataract surgery with KDB in a single surgical center at Montefiore Medical Center with a single provider

Age in the registry: 30 years to 100 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

Site	City	Country	Site status
Montefiore Wakefield Campus Coordinator of this site? Confirm its status	The Bronx	United States	Recruiting
Montefiore Medical Center Coordinator of this site? Confirm its status	The Bronx	United States	Recruiting

This page is information, not medical advice. Discuss any trial with your doctor.